Friday Aug 8
ZIOPHARM, Inc. Reports Second-Quarter 2014 Financial Results And Reviews Recent Activities
ZIOPHARM Oncology, Inc. today announced financial results for the second quarter ended June 30, 2014, and provided an update on the company's product development activities.
ZIOPHARM Oncology (ZIOP) Releases Quarterly Earnings Results
ZIOPHARM Oncology posted its quarterly earnings results on Thursday. The company reported earnings per share for the quarter, beating the analysts' consensus estimate of by $0.11, Analyst Ratings Network.com reports.
Biotech Equities Technical Analysis -- BioMarin Pharma, Merrimack...
However the gains were not broad based as six out of ten sectors ended the session in negative.
ZIOPHARM Oncology, Inc. And Solasia Pharma K.K. Announce Global...
ZIOPHARM Oncology, Inc. , a biopharmaceutical company focused on the development and commercialization of new cancer therapies, and Solasia Pharma K.K. , a developer of oncology pharmaceuticals in-licensed for commercialization in major markets throughout the world, announced today an amendment and restatement of their License and Collaboration ... (more)
ZIOPHARM, Inc. Announces Expansion Of Ground-Breaking Synthetic...
ZIOPHARM Oncology, Inc. , a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced the expansion of synthetic immuno-oncology programs in conjunction with Intrexon Corporation to include chimeric antigen receptor T-cell therapy.